Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Locally-advanced Rectal Cancer × Folfox protocol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 118 Colonic Neoplasms 52 Rectal Neoplasms 46 Carcinoma, Hepatocellular 26 Neoplasm Metastasis 22 Stomach Neoplasms 20 Neoplasms 10 Pancreatic Neoplasms 9 Cholangiocarcinoma 8 Adenocarcinoma Of Esophagus 7 Liver Neoplasms 6 Esophageal Neoplasms 6 Biliary Tract Neoplasms 5 Recurrence 4 Gastrointestinal Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Esophageal Squamous Cell Carcinoma 3 Digestive System Neoplasms 3 Breast Neoplasms 3 Adenocarcinoma 3 Ovarian Neoplasms 2 Neurotoxicity Syndromes 2 Neoplastic Cells, Circulating 2 Gastrointestinal Diseases 2 Gallbladder Neoplasms 2 Cirrhosis, Familial, with Pulmonary Hypertension 2 Unresectable Metastatic Colorectal Cancer 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumors 1 Prostatic Neoplasms 1

Interventions

Oxaliplatin 1 Folfox protocol 1 Capecitabine 1 ASTX-660 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05912075 2024-02-08

PRAAR1

Gustave Roussy, Cancer Campus, Grand Paris

Phase 1 Recruiting

Gastrointestinal

Locally-advanced Rectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡